Home
About
FAQ
History (32)
Can a Point-of-Care Troponin I Assay be as Good as a Central Laboratory Assay? A MIDAS Investigation
Dietary fructose induces endotoxemia and hepatic injury in calorically controlled primates.
Factors affecting prescription of ultra-high potency topical corticosteroids in skin disease: an analysis of US national practice data.
Impact of smoking reduced nicotine content cigarettes on sensitivity to cigarette price: further results from a multi-site clinical trial.
Comparing the SPRINT and the HOPE-3 Blood Pressure Trial.
See All 32 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Comparing the SPRINT and the HOPE-3 Blood Pressure Trial.
Whelton PK, Reboussin DM, Fine LJ. Comparing the SPRINT and the HOPE-3 Blood Pressure Trial. JAMA Cardiol. 2016 11 01; 1(8):855-856.
View in:
PubMed
subject areas
Antihypertensive Agents
Blood Pressure
Blood Pressure Determination
Clinical Trials as Topic
Humans
Hypertension
authors with profiles
David M. Reboussin PhD